Concomitant use of dextromethorphan and alcohol‐induced dissociation in a patient with alcohol dependence
Authors:
Open Access
- 4 October 2024
- journal article
- research article
- Published by Wiley in Psychiatry and Clinical Neurosciences Reports
- Vol. 3 (4) , e70011
Abstract
Background: Dextromethorphan (DXM) is an over‐the‐counter drug that is commonly abused by teenagers. Its main pharmacological property is a low‐affinity N‐methyl‐d‐aspartate (NMDA) receptor antagonist.Case Presentation: We report acute psychotic dissociation induced by DXM and alcohol in a patient with alcohol dependence, which made it difficult to distinguish alcohol withdrawal symptoms with limited information. The psychotic symptoms were ameliorated by haloperidol; however, in cases of DXM abuse, haloperidol treatment should be avoided.Conclusion: In the consultation of patients with addiction, the possibility of various addictive drugs must be kept in mind. The concomitant use of DXM and alcohol causes easy dissociation and high‐dose usage of DXM and alcohol withdrawal symptoms are difficult to distinguish.Keywords
This publication has 11 references indexed in Scilit:
- Dextromethorphan in Cough Syrup: The Poor Man’s PsychosisPsychopharmacology Bulletin, 2025
- Antipsychotic Drugs Efficacy in Dextromethorphan-Induced PsychosisBiomedicines, 2023
- Dextromethorphan Abuse Among Opioid-Dependent PatientsClinical Neuropharmacology, 2020
- Lack of Efficacy of Dextromethorphan in Managing Alcohol WithdrawalJournal of Clinical Psychopharmacology, 2014
- Dextromethorphan Abuse Leading to Assault, Suicide, or HomicideJournal of Forensic Sciences, 2012
- Five Deaths Resulting from Abuse of Dextromethorphan Sold Over the InternetJournal of Analytical Toxicology, 2009
- The role of GABAA receptors in the development of alcoholismPharmacology Biochemistry and Behavior, 2008
- Dextromethorphan Abuse in AdolescenceArchives of Pediatrics & Adolescent Medicine, 2006
- Potent inhibition of CYP2D6 by haloperidol metabolites: stereoselective inhibition by reduced haloperidolBritish Journal of Clinical Pharmacology, 2001
- International statistical classification of diseases and related health problems. Tenth revision.1988